Back

RNA interference - Building oligonucleotides as therapeutics

2 September 2019 (18:35 - 18:50)
Organised by:
Congress Presentation Part of: Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease? Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr David Corey

Dallas (United States of America)

5 More presentations in this session

Presentation thumbnail
Introduction and purpose
Doctor B. Berkowitz (New York, US)
Slides Video
Presentation thumbnail
LDL-C: The race to the bottom
Professor E. Braunwald (Boston, US)
Slides Video
Presentation thumbnail
Cumulative exposure - Estimating the benefits of intervention
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
With recent news - here's what's possible
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
Panel and audience questions and answers
Doctor B. Berkowitz (New York, US)
Slides Video

Access the full session

Session thumbnail
Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

The Event

Event poster

ESC Congress 2019

2 September 2019 18:35 CET
You may be interested in
thumbnail
Congress Session
RNA-based therapy in cardiovascular disease: ready for prime time!
27 August 2023
thumbnail
Congress Presentation
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
13 April 2024
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Towards advanced cardiac miRNA therapies through DNA-based nanostructures
29 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources